{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:04:57Z","timestamp":1791072297132,"version":"4.1.0"},"reference-count":0,"publisher":"Wiley","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1067\/mcp.2000.105990","type":"journal-article","created":{"date-parts":[[2003,11,13]],"date-time":"2003-11-13T12:16:51Z","timestamp":1068725811000},"page":"478-488","source":"Crossref","is-referenced-by-count":50,"title":["Investigations of the metabolites of the trypanocidal drug melarsoprol"],"prefix":"10.1111","volume":"67","author":[{"given":"J","family":"Keiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:15:00Z","timestamp":1699362900000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1067\/mcp.2000.105990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["S0009-9236(00)22718-5"],"URL":"https:\/\/doi.org\/10.1067\/mcp.2000.105990","relation":{},"ISSN":["0009-9236"],"issn-type":[{"value":"0009-9236","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}